REMS
Mycobacterium avium
complex (MAC) lung disease in patients who have limited or no other treatment options and who do not achieve negative sputum cultures after ≥6 consecutive months of a multidrug treatment regimen (in combination with other antibacterial drugs).Spectrum:
Absorption: Poorly absorbed from the GI tract. Well absorbed after IM administration. IV administration results in complete bioavailability. Absorption variable after administration via inhalation.
Distribution: Widely distributed throughout extracellular fluid. Crosses the placenta; small amounts enter breast milk. Poor penetration into CSF (↑ when meninges inflamed).
Half-Life: Infants >7 days: 45 hr; Children: 1.62.5 hr; Adolescents: 0.52.5 hr; Adults: 23 hr (↑ in renal impairment, ↓ in patients with burns); 620 hr (with inhalation).
(peak blood levels)
ROUTE | ONSET | PEAK | DURATION |
IM | rapid | 0.752 hr | 1224 hr |
IV | rapid | within 30 min of 30 min infusion | 1224 hr |
Inhaln | Unknown | Unknown | Unknown |
Contraindicated in:
Use Cautiously in:
Derm: rash (inhalation only)
EENT: ototoxicity (vestibular and cochlear), voice alteration (inhalation only), epistaxis(inhalation only), oral candidiasis(inhalation only)
GI: diarrhea (inhalation only), nausea (inhalation only), dry mouth (inhalation only), metallic taste (inhalation only), vomiting(inhalation only)
GU: nephrotoxicity
Neuro: headache (inhalation only), enhanced neuromuscular blockade, anxiety(inhalation only), vertigo
Resp: bronchospasm(inhalation only), cough (inhalation only), hemoptysis (inhalation only), apnea, hypersensitivity pneumonitis(inhalation only)
Drug-drug:
Inhaln
(Adults ): 590 mg once daily.Renal Impairment
Lab Test Considerations:
Toxicity and Overdose:
IV Administration: